Skip to main content
OpenTrials
Completed

NCT Number: NCT00622063

An Extension Study for Patients Previously Treated With ARQ 501

To provide ongoing treatment with ARQ 501 for patients who have benefited from prior treatment with ARQ 501

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cancer Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1 / Phase 2

Primary location

Mary Crowley Medical Research Center

Dallas, Texas, 75246, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Signed written informed consent
  • Has previous participated in a clinical trial with ARQ 501 and is eligible for continued treatment

Exclusion criteria

  • Have not received previous treatment with ARQ 501 under a treatment protocol
  • Uncontrolled intercurrent illness, uncontrolled infection or psychiatric illness/social situations that would limit compliance with study requirements

Treatment and study plan

ARQ 501

Drug

Treatment with ARQ 501 or ARQ 501 as combination therapy at the dose and regimen previously received

Primary outcomes

  1. To provide ongoing treatment with ARQ 501 for patients who have benefited from prior treatment with ARQ 501

    Time frame: No time frame

Secondary outcomes

  1. To collect additional safety and tolerability information for ARQ 501 treatment

    Time frame: No time frame

Sponsors and collaborators

Lead sponsor

ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)

Industry

Registry information

Important dates

Study start
2006
Primary completion
2008
First posted
Feb 22, 2008
Registry last updated
Feb 28, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.